These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 31711379)
21. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein. Chen Y; Lu S; Jia H; Deng Y; Zhou J; Huang B; Yu Y; Lan J; Wang W; Lou Y; Qin K; Tan W Emerg Microbes Infect; 2017 May; 6(5):e37. PubMed ID: 28536429 [TBL] [Abstract][Full Text] [Related]
22. MERS-CoV spike protein: Targets for vaccines and therapeutics. Wang Q; Wong G; Lu G; Yan J; Gao GF Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951 [TBL] [Abstract][Full Text] [Related]
23. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227 [TBL] [Abstract][Full Text] [Related]
24. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Guo X; Deng Y; Chen H; Lan J; Wang W; Zou X; Hung T; Lu Z; Tan W Immunology; 2015 Aug; 145(4):476-84. PubMed ID: 25762305 [TBL] [Abstract][Full Text] [Related]
25. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia. Kasem S; Qasim I; Al-Hufofi A; Hashim O; Alkarar A; Abu-Obeida A; Gaafer A; Elfadil A; Zaki A; Al-Romaihi A; Babekr N; El-Harby N; Hussien R; Al-Sahaf A; Al-Doweriej A; Bayoumi F; Poon LLM; Chu DKW; Peiris M; Perera RAPM J Infect Public Health; 2018; 11(3):331-338. PubMed ID: 28993171 [TBL] [Abstract][Full Text] [Related]
26. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Ali M; El-Shesheny R; Kandeil A; Shehata M; Elsokary B; Gomaa M; Hassan N; El Sayed A; El-Taweel A; Sobhy H; Fasina FO; Dauphin G; El Masry I; Wolde AW; Daszak P; Miller M; VonDobschuetz S; Morzaria S; Lubroth J; Makonnen YJ Euro Surveill; 2017 Mar; 22(11):. PubMed ID: 28333616 [TBL] [Abstract][Full Text] [Related]
27. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors. Widagdo W; Okba NMA; Li W; de Jong A; de Swart RL; Begeman L; van den Brand JMA; Bosch BJ; Haagmans BL J Virol; 2019 Aug; 93(16):. PubMed ID: 31167913 [TBL] [Abstract][Full Text] [Related]
28. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice]. Lan J; Lu S; Deng Y; Wen B; Chen H; Wang W; Tan W Bing Du Xue Bao; 2016 Jan; 32(1):77-81. PubMed ID: 27295887 [TBL] [Abstract][Full Text] [Related]
29. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir. Mohd HA; Al-Tawfiq JA; Memish ZA Virol J; 2016 Jun; 13():87. PubMed ID: 27255185 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas. Adney DR; Wang L; van Doremalen N; Shi W; Zhang Y; Kong WP; Miller MR; Bushmaker T; Scott D; de Wit E; Modjarrad K; Petrovsky N; Graham BS; Bowen RA; Munster VJ Viruses; 2019 Mar; 11(3):. PubMed ID: 30832356 [TBL] [Abstract][Full Text] [Related]
31. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Adney DR; van Doremalen N; Brown VR; Bushmaker T; Scott D; de Wit E; Bowen RA; Munster VJ Emerg Infect Dis; 2014 Dec; 20(12):1999-2005. PubMed ID: 25418529 [TBL] [Abstract][Full Text] [Related]
32. Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection Adney DR; Letko M; Ragan IK; Scott D; van Doremalen N; Bowen RA; Munster VJ Emerg Microbes Infect; 2019; 8(1):717-723. PubMed ID: 31119984 [TBL] [Abstract][Full Text] [Related]
33. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Alharbi NK; Padron-Regalado E; Thompson CP; Kupke A; Wells D; Sloan MA; Grehan K; Temperton N; Lambe T; Warimwe G; Becker S; Hill AVS; Gilbert SC Vaccine; 2017 Jun; 35(30):3780-3788. PubMed ID: 28579232 [TBL] [Abstract][Full Text] [Related]
34. Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya. Ommeh S; Zhang W; Zohaib A; Chen J; Zhang H; Hu B; Ge XY; Yang XL; Masika M; Obanda V; Luo Y; Li S; Waruhiu C; Li B; Zhu Y; Ouma D; Odendo V; Wang LF; Anderson DE; Lichoti J; Mungube E; Gakuya F; Zhou P; Ngeiywa KJ; Yan B; Agwanda B; Shi ZL Virol Sin; 2018 Dec; 33(6):484-492. PubMed ID: 30570714 [TBL] [Abstract][Full Text] [Related]
35. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of candidate vaccine approaches for MERS-CoV. Wang L; Shi W; Joyce MG; Modjarrad K; Zhang Y; Leung K; Lees CR; Zhou T; Yassine HM; Kanekiyo M; Yang ZY; Chen X; Becker MM; Freeman M; Vogel L; Johnson JC; Olinger G; Todd JP; Bagci U; Solomon J; Mollura DJ; Hensley L; Jahrling P; Denison MR; Rao SS; Subbarao K; Kwong PD; Mascola JR; Kong WP; Graham BS Nat Commun; 2015 Jul; 6():7712. PubMed ID: 26218507 [TBL] [Abstract][Full Text] [Related]
37. Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia. Al-Shomrani BM; Manee MM; Alharbi SN; Altammami MA; Alshehri MA; Nassar MS; Bakhrebah MA; Al-Fageeh MB Viruses; 2020 Jun; 12(6):. PubMed ID: 32503352 [TBL] [Abstract][Full Text] [Related]
38. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review. Choi J; Kim MG; Oh YK; Kim YB Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202 [TBL] [Abstract][Full Text] [Related]
39. Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction. Omrani AS; Al-Tawfiq JA; Memish ZA Pathog Glob Health; 2015; 109(8):354-62. PubMed ID: 26924345 [TBL] [Abstract][Full Text] [Related]
40. Molecular aspects of MERS-CoV. Rabaan AA; Bazzi AM; Al-Ahmed SH; Al-Tawfiq JA Front Med; 2017 Sep; 11(3):365-377. PubMed ID: 28500431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]